Sewoon Medical Income Statement

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Revenue	63,657	60,151	68,247	60,116	62,579
Other Revenue	-	-	-0	-	-
Revenue	63,657	60,151	68,247	60,116	62,579
Revenue Growth (YoY)	5.83%	-11.86%	13.53%	-3.94%	-1.80%
Cost of Revenue	40,112	37,963	40,689	37,896	37,522
Gross Profit	23,545	22,188	27,557	22,220	25,057
Selling, General & Admin	9,454	9,468	9,330	8,734	8,466
Research & Development	456.39	510.42	468.21	505.09	427.87
Amortization of Goodwill & Intangibles	242.33	149.71	143.91	152.41	87.82
Operating Expenses	10,844	10,811	10,637	10,033	9,671
Operating Income	12,701	11,377	16,920	12,187	15,386
Interest Expense	-35.52	-36.63	-36.08	-35.81	-31.47
Interest & Investment Income	2,065	2,331	1,969	736.18	172.83
Currency Exchange Gain (Loss)	143.09	1,597	357.41	702.87	1,035
Other Non Operating Income (Expenses)	-7.96	73.35	69.67	38.25	67.05
EBT Excluding Unusual Items	14,865	15,342	19,280	13,629	16,630
Gain (Loss) on Sale of Assets	36.61	279.54	17.79	2.2	-0.67
Asset Writedown	-	-	-	-2	-2.96
Pretax Income	14,902	15,621	19,298	13,629	16,626
Income Tax Expense	2,709	3,046	3,824	2,990	3,864
Earnings From Continuing Operations	12,193	12,575	15,474	10,639	12,762
Net Income to Company	12,193	12,575	15,474	10,639	12,762
Minority Interest in Earnings	-280.57	-412.61	-517.02	-232.69	-480.5
Net Income	11,912	12,163	14,957	10,406	12,282
Net Income to Common	11,912	12,163	14,957	10,406	12,282
Net Income Growth	-2.06%	-18.68%	43.73%	-15.27%	17.02%
Shares Outstanding (Basic)	43	43	43	43	43
Shares Outstanding (Diluted)	43	43	43	43	43
Shares Change (YoY)	-1.36%	-0.02%	-	-	-
EPS (Basic)	279.00	281.00	345.50	240.38	283.70
EPS (Diluted)	279.00	281.00	345.50	240.38	283.70
EPS Growth	-0.71%	-18.67%	43.73%	-15.27%	17.02%
Free Cash Flow	16,083	11,750	21,127	7,128	19,244
Free Cash Flow Per Share	376.68	271.47	488.02	164.65	444.53
Dividend Per Share	-	-	70.000	60.000	50.000
Dividend Growth	-	-	16.67%	20.00%	-
Gross Margin	36.99%	36.89%	40.38%	36.96%	40.04%
Operating Margin	19.95%	18.91%	24.79%	20.27%	24.59%
Profit Margin	18.71%	20.22%	21.92%	17.31%	19.63%
Free Cash Flow Margin	25.26%	19.54%	30.96%	11.86%	30.75%
EBITDA	16,021	14,857	20,568	16,075	19,222
EBITDA Margin	25.17%	24.70%	30.14%	26.74%	30.72%
D&A For EBITDA	3,320	3,480	3,648	3,888	3,836
EBIT	12,701	11,377	16,920	12,187	15,386
EBIT Margin	19.95%	18.91%	24.79%	20.27%	24.59%
Effective Tax Rate	18.18%	19.50%	19.82%	21.94%	23.24%
Advertising Expenses	281.21	294.06	233.54	186.34	76.21

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.